Susan Johnson
Concepts (391)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Feeding Behavior | 58 | 2025 | 679 | 9.350 |
Why?
| | Food Preferences | 23 | 2025 | 124 | 5.860 |
Why?
| | Infant Nutritional Physiological Phenomena | 13 | 2025 | 144 | 5.260 |
Why?
| | Vegetables | 16 | 2025 | 161 | 4.480 |
Why?
| | Diet | 31 | 2025 | 1277 | 4.160 |
Why?
| | Health Promotion | 19 | 2025 | 749 | 3.440 |
Why?
| | Poverty | 26 | 2025 | 527 | 2.940 |
Why?
| | Meals | 14 | 2023 | 132 | 2.810 |
Why?
| | Caregivers | 10 | 2025 | 940 | 2.720 |
Why?
| | Child, Preschool | 87 | 2025 | 11511 | 2.710 |
Why?
| | Mothers | 19 | 2023 | 776 | 2.510 |
Why?
| | Energy Intake | 27 | 2025 | 510 | 2.490 |
Why?
| | Infant Food | 5 | 2024 | 64 | 2.410 |
Why?
| | Child Nutritional Physiological Phenomena | 16 | 2021 | 107 | 2.320 |
Why?
| | Taste | 9 | 2021 | 229 | 2.240 |
Why?
| | Nutritional Sciences | 7 | 2020 | 37 | 2.180 |
Why?
| | Health Education | 8 | 2021 | 360 | 1.930 |
Why?
| | Parent-Child Relations | 10 | 2021 | 285 | 1.880 |
Why?
| | Parents | 21 | 2025 | 1439 | 1.830 |
Why?
| | Obesity | 30 | 2022 | 3007 | 1.800 |
Why?
| | Meat | 3 | 2025 | 93 | 1.780 |
Why?
| | Food | 9 | 2023 | 160 | 1.730 |
Why?
| | Parenting | 14 | 2021 | 319 | 1.630 |
Why?
| | Child Behavior | 11 | 2020 | 250 | 1.600 |
Why?
| | Child Development | 13 | 2020 | 496 | 1.600 |
Why?
| | Eating | 18 | 2021 | 393 | 1.470 |
Why?
| | Pediatric Obesity | 11 | 2023 | 604 | 1.420 |
Why?
| | Health Knowledge, Attitudes, Practice | 7 | 2022 | 1395 | 1.360 |
Why?
| | Fruit | 8 | 2021 | 146 | 1.340 |
Why?
| | Breast Feeding | 8 | 2025 | 441 | 1.320 |
Why?
| | Decision Making | 3 | 2025 | 949 | 1.310 |
Why?
| | Nutritional Status | 5 | 2022 | 357 | 1.290 |
Why?
| | Infant | 29 | 2025 | 9820 | 1.280 |
Why?
| | Food Services | 7 | 2020 | 21 | 1.280 |
Why?
| | Humans | 148 | 2025 | 141284 | 1.180 |
Why?
| | Child Care | 4 | 2023 | 33 | 1.180 |
Why?
| | Exercise | 10 | 2025 | 2113 | 1.150 |
Why?
| | Mobile Applications | 4 | 2025 | 185 | 1.100 |
Why?
| | Rural Population | 8 | 2025 | 602 | 1.070 |
Why?
| | Mexican Americans | 6 | 2018 | 112 | 1.030 |
Why?
| | Health Behavior | 9 | 2025 | 784 | 1.000 |
Why?
| | Body Weight | 10 | 2020 | 992 | 0.960 |
Why?
| | Female | 92 | 2025 | 75814 | 0.940 |
Why?
| | Surveys and Questionnaires | 20 | 2025 | 5948 | 0.920 |
Why?
| | Portion Size | 3 | 2017 | 6 | 0.910 |
Why?
| | Family Characteristics | 2 | 2025 | 191 | 0.860 |
Why?
| | Male | 83 | 2025 | 70140 | 0.850 |
Why?
| | Developmental Disabilities | 2 | 2025 | 288 | 0.830 |
Why?
| | Brassica | 2 | 2023 | 5 | 0.830 |
Why?
| | Food Supply | 2 | 2021 | 90 | 0.790 |
Why?
| | Dietary Supplements | 4 | 2022 | 572 | 0.790 |
Why?
| | Nutrition Policy | 3 | 2021 | 56 | 0.790 |
Why?
| | Food Labeling | 2 | 2021 | 15 | 0.780 |
Why?
| | Body Mass Index | 21 | 2023 | 2390 | 0.780 |
Why?
| | Child Day Care Centers | 5 | 2025 | 39 | 0.780 |
Why?
| | Iron | 1 | 2024 | 324 | 0.730 |
Why?
| | Schools | 9 | 2021 | 451 | 0.730 |
Why?
| | Self Care | 2 | 2023 | 387 | 0.730 |
Why?
| | Nutritional Requirements | 7 | 2019 | 81 | 0.720 |
Why?
| | Adult | 53 | 2025 | 39319 | 0.720 |
Why?
| | Language Development | 1 | 2022 | 68 | 0.700 |
Why?
| | Qualitative Research | 5 | 2025 | 1519 | 0.700 |
Why?
| | Zinc | 1 | 2024 | 298 | 0.690 |
Why?
| | Maternal Behavior | 5 | 2018 | 80 | 0.690 |
Why?
| | Cross-Sectional Studies | 22 | 2025 | 5653 | 0.690 |
Why?
| | Child | 47 | 2025 | 22390 | 0.680 |
Why?
| | Hunger | 7 | 2021 | 54 | 0.670 |
Why?
| | Students | 4 | 2021 | 644 | 0.660 |
Why?
| | Writing | 1 | 2021 | 99 | 0.630 |
Why?
| | Overweight | 5 | 2015 | 589 | 0.630 |
Why?
| | Nutritive Value | 7 | 2024 | 37 | 0.620 |
Why?
| | Exploratory Behavior | 1 | 2020 | 89 | 0.610 |
Why?
| | School Teachers | 2 | 2019 | 29 | 0.610 |
Why?
| | Climate Change | 1 | 2021 | 187 | 0.590 |
Why?
| | Feeding and Eating Disorders of Childhood | 1 | 2018 | 7 | 0.570 |
Why?
| | School Health Services | 2 | 2020 | 233 | 0.560 |
Why?
| | Nutrition Surveys | 2 | 2020 | 280 | 0.560 |
Why?
| | Phobic Disorders | 1 | 2018 | 36 | 0.560 |
Why?
| | Food Handling | 1 | 2018 | 65 | 0.550 |
Why?
| | Checklist | 1 | 2019 | 106 | 0.550 |
Why?
| | Self-Assessment | 1 | 2018 | 75 | 0.540 |
Why?
| | Television | 5 | 2019 | 71 | 0.530 |
Why?
| | Family Relations | 2 | 2016 | 90 | 0.530 |
Why?
| | Mother-Child Relations | 8 | 2019 | 135 | 0.500 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2018 | 552 | 0.480 |
Why?
| | Colorado | 15 | 2021 | 4599 | 0.480 |
Why?
| | Appetite | 5 | 2023 | 71 | 0.480 |
Why?
| | Social Marketing | 2 | 2007 | 16 | 0.480 |
Why?
| | Nutrition Assessment | 5 | 2021 | 92 | 0.480 |
Why?
| | Autism Spectrum Disorder | 4 | 2025 | 418 | 0.470 |
Why?
| | Research Design | 5 | 2018 | 1105 | 0.460 |
Why?
| | Pleasure | 2 | 2014 | 18 | 0.450 |
Why?
| | Photography | 6 | 2021 | 114 | 0.440 |
Why?
| | Dietary Fats | 8 | 2020 | 303 | 0.430 |
Why?
| | Communication | 4 | 2020 | 941 | 0.430 |
Why?
| | Dietary Carbohydrates | 4 | 2010 | 151 | 0.430 |
Why?
| | Longitudinal Studies | 9 | 2020 | 2929 | 0.430 |
Why?
| | Cues | 3 | 2013 | 323 | 0.430 |
Why?
| | Paternal Behavior | 1 | 2014 | 5 | 0.430 |
Why?
| | Diet Records | 6 | 2025 | 83 | 0.420 |
Why?
| | Consumer Behavior | 4 | 2021 | 71 | 0.420 |
Why?
| | Psychometrics | 4 | 2019 | 736 | 0.410 |
Why?
| | United States | 18 | 2025 | 15298 | 0.400 |
Why?
| | Self Report | 6 | 2019 | 859 | 0.390 |
Why?
| | Family Health | 1 | 2014 | 194 | 0.390 |
Why?
| | Reproducibility of Results | 10 | 2022 | 3345 | 0.390 |
Why?
| | Dietary Proteins | 3 | 2010 | 135 | 0.370 |
Why?
| | Sleep Wake Disorders | 1 | 2016 | 305 | 0.360 |
Why?
| | Visual Perception | 2 | 2011 | 177 | 0.360 |
Why?
| | Failure to Thrive | 2 | 2009 | 28 | 0.350 |
Why?
| | Restaurants | 2 | 2021 | 22 | 0.350 |
Why?
| | Educational Status | 3 | 2023 | 463 | 0.340 |
Why?
| | Size Perception | 1 | 2010 | 6 | 0.340 |
Why?
| | Child Development Disorders, Pervasive | 3 | 2018 | 62 | 0.340 |
Why?
| | Interviews as Topic | 5 | 2025 | 839 | 0.340 |
Why?
| | Professional-Family Relations | 2 | 2011 | 152 | 0.340 |
Why?
| | Mental Recall | 4 | 2021 | 209 | 0.330 |
Why?
| | Lunch | 3 | 2020 | 8 | 0.330 |
Why?
| | Satiation | 5 | 2023 | 28 | 0.320 |
Why?
| | Motor Activity | 5 | 2015 | 717 | 0.320 |
Why?
| | Medicine, Traditional | 1 | 2009 | 24 | 0.320 |
Why?
| | Child Health | 3 | 2022 | 153 | 0.310 |
Why?
| | Focus Groups | 5 | 2019 | 565 | 0.310 |
Why?
| | Dietary Sugars | 2 | 2020 | 17 | 0.310 |
Why?
| | Texas | 4 | 2020 | 267 | 0.300 |
Why?
| | Sleep | 1 | 2016 | 882 | 0.290 |
Why?
| | Motor Skills | 2 | 2021 | 105 | 0.280 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2014 | 2529 | 0.280 |
Why?
| | Hyperglycemia | 2 | 2014 | 365 | 0.270 |
Why?
| | Social Control, Informal | 2 | 2013 | 21 | 0.270 |
Why?
| | Program Evaluation | 6 | 2021 | 919 | 0.260 |
Why?
| | Mass Screening | 2 | 2006 | 1309 | 0.260 |
Why?
| | Cell Phone | 2 | 2018 | 82 | 0.260 |
Why?
| | Motivation | 1 | 2011 | 600 | 0.250 |
Why?
| | Middle Aged | 21 | 2025 | 34658 | 0.250 |
Why?
| | Cultural Characteristics | 3 | 2018 | 65 | 0.240 |
Why?
| | Food, Fortified | 3 | 2022 | 42 | 0.240 |
Why?
| | Principal Component Analysis | 2 | 2018 | 197 | 0.240 |
Why?
| | Red Meat | 1 | 2025 | 17 | 0.230 |
Why?
| | Diabetes, Gestational | 2 | 2022 | 318 | 0.230 |
Why?
| | Hypoglycemia | 1 | 2010 | 470 | 0.230 |
Why?
| | Insulin Infusion Systems | 1 | 2010 | 480 | 0.230 |
Why?
| | Micronutrients | 2 | 2025 | 92 | 0.230 |
Why?
| | Appetite Regulation | 3 | 2023 | 32 | 0.230 |
Why?
| | Weight Gain | 6 | 2020 | 536 | 0.220 |
Why?
| | Program Development | 2 | 2017 | 364 | 0.210 |
Why?
| | Washington | 3 | 2020 | 159 | 0.210 |
Why?
| | Autistic Disorder | 2 | 2022 | 211 | 0.210 |
Why?
| | India | 3 | 2020 | 210 | 0.210 |
Why?
| | Young Adult | 14 | 2020 | 13727 | 0.210 |
Why?
| | Insulin | 2 | 2014 | 2472 | 0.200 |
Why?
| | Adolescent | 16 | 2021 | 22116 | 0.200 |
Why?
| | Food Quality | 2 | 2021 | 10 | 0.200 |
Why?
| | Glucagon-Like Peptide 1 | 2 | 2014 | 133 | 0.190 |
Why?
| | Diabetic Nephropathies | 1 | 2006 | 293 | 0.190 |
Why?
| | Cattle | 1 | 2025 | 982 | 0.190 |
Why?
| | Pilot Projects | 2 | 2025 | 1820 | 0.190 |
Why?
| | Snacks | 2 | 2020 | 24 | 0.190 |
Why?
| | Vocabulary | 1 | 2022 | 37 | 0.180 |
Why?
| | Self Efficacy | 3 | 2020 | 404 | 0.180 |
Why?
| | Choice Behavior | 3 | 2021 | 171 | 0.170 |
Why?
| | Economics, Behavioral | 1 | 2021 | 9 | 0.170 |
Why?
| | Teaching | 1 | 2003 | 233 | 0.170 |
Why?
| | Nutrition Therapy | 1 | 2021 | 36 | 0.170 |
Why?
| | Perception | 4 | 2021 | 375 | 0.170 |
Why?
| | Infant Nutrition Disorders | 1 | 2020 | 10 | 0.170 |
Why?
| | Infant, Newborn | 8 | 2022 | 6270 | 0.170 |
Why?
| | Energy Metabolism | 7 | 2013 | 926 | 0.170 |
Why?
| | Mindfulness | 1 | 2023 | 149 | 0.160 |
Why?
| | Cardiovascular Diseases | 2 | 2023 | 2091 | 0.160 |
Why?
| | Beverages | 3 | 2015 | 65 | 0.160 |
Why?
| | Acculturation | 1 | 2020 | 53 | 0.160 |
Why?
| | Behavior Observation Techniques | 1 | 2019 | 10 | 0.160 |
Why?
| | Teacher Training | 1 | 2019 | 7 | 0.150 |
Why?
| | Case-Control Studies | 2 | 2025 | 3577 | 0.150 |
Why?
| | Language | 1 | 2022 | 310 | 0.150 |
Why?
| | Child Nutrition Sciences | 2 | 2012 | 8 | 0.150 |
Why?
| | Social Support | 1 | 2023 | 629 | 0.150 |
Why?
| | Body Composition | 4 | 2010 | 704 | 0.140 |
Why?
| | Epigenesis, Genetic | 1 | 2023 | 661 | 0.140 |
Why?
| | Patient Compliance | 3 | 2017 | 607 | 0.140 |
Why?
| | DNA Methylation | 1 | 2023 | 643 | 0.140 |
Why?
| | Visual Analog Scale | 1 | 2018 | 35 | 0.140 |
Why?
| | Premature Birth | 1 | 2022 | 363 | 0.140 |
Why?
| | Weaning | 2 | 2012 | 46 | 0.140 |
Why?
| | Sodium, Dietary | 1 | 2018 | 38 | 0.140 |
Why?
| | Dietary Sucrose | 2 | 2015 | 48 | 0.140 |
Why?
| | Housing | 1 | 2019 | 146 | 0.140 |
Why?
| | Evidence-Based Practice | 4 | 2022 | 229 | 0.130 |
Why?
| | Cohort Studies | 5 | 2017 | 5809 | 0.130 |
Why?
| | Goals | 1 | 2018 | 177 | 0.130 |
Why?
| | Employment | 1 | 2018 | 180 | 0.130 |
Why?
| | Lipids | 1 | 2021 | 686 | 0.130 |
Why?
| | Reward | 1 | 2019 | 248 | 0.120 |
Why?
| | Telemedicine | 1 | 2025 | 893 | 0.120 |
Why?
| | Minority Health | 1 | 2016 | 17 | 0.120 |
Why?
| | Health Personnel | 1 | 2022 | 727 | 0.120 |
Why?
| | Adolescent Behavior | 1 | 2021 | 538 | 0.120 |
Why?
| | Age Factors | 4 | 2013 | 3295 | 0.120 |
Why?
| | Health Status Disparities | 1 | 2018 | 303 | 0.120 |
Why?
| | Self-Control | 1 | 2016 | 57 | 0.120 |
Why?
| | Candy | 1 | 2015 | 5 | 0.110 |
Why?
| | Diet, Fat-Restricted | 2 | 2008 | 77 | 0.110 |
Why?
| | Population Surveillance | 1 | 2018 | 481 | 0.110 |
Why?
| | Anthropometry | 3 | 2021 | 208 | 0.110 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2016 | 1610 | 0.110 |
Why?
| | Linear Models | 2 | 2015 | 855 | 0.110 |
Why?
| | Hypoglycemic Agents | 2 | 2014 | 1380 | 0.110 |
Why?
| | Health | 1 | 2015 | 83 | 0.110 |
Why?
| | Quality Improvement | 1 | 2023 | 1241 | 0.110 |
Why?
| | Insulin Lispro | 1 | 2014 | 42 | 0.110 |
Why?
| | Sulfonylurea Compounds | 1 | 2014 | 50 | 0.110 |
Why?
| | Insulin, Long-Acting | 1 | 2014 | 64 | 0.100 |
Why?
| | Executive Function | 1 | 2019 | 459 | 0.100 |
Why?
| | Income | 1 | 2015 | 198 | 0.100 |
Why?
| | Urban Health | 1 | 2014 | 95 | 0.100 |
Why?
| | Life Style | 2 | 2014 | 479 | 0.100 |
Why?
| | Pyrazines | 1 | 2014 | 88 | 0.100 |
Why?
| | Reference Values | 2 | 2015 | 803 | 0.100 |
Why?
| | Triazoles | 1 | 2014 | 163 | 0.100 |
Why?
| | Animals | 2 | 2025 | 37328 | 0.090 |
Why?
| | Growth | 1 | 2012 | 52 | 0.090 |
Why?
| | Hypertriglyceridemia | 1 | 2012 | 39 | 0.090 |
Why?
| | Analysis of Variance | 3 | 2017 | 1312 | 0.090 |
Why?
| | Sex Factors | 4 | 2015 | 2055 | 0.090 |
Why?
| | Community Health Nursing | 1 | 2012 | 63 | 0.090 |
Why?
| | Apolipoprotein C-III | 1 | 2011 | 12 | 0.090 |
Why?
| | Attitude | 2 | 2018 | 257 | 0.090 |
Why?
| | Sweetening Agents | 1 | 2012 | 55 | 0.090 |
Why?
| | Eicosapentaenoic Acid | 1 | 2011 | 36 | 0.090 |
Why?
| | Heptanoic Acids | 1 | 2011 | 66 | 0.090 |
Why?
| | Follow-Up Studies | 4 | 2018 | 5222 | 0.090 |
Why?
| | Trace Elements | 1 | 2011 | 51 | 0.090 |
Why?
| | Docosahexaenoic Acids | 1 | 2011 | 85 | 0.080 |
Why?
| | Infusions, Subcutaneous | 1 | 2010 | 23 | 0.080 |
Why?
| | Diet Surveys | 3 | 2006 | 91 | 0.080 |
Why?
| | Feeding Methods | 1 | 2010 | 6 | 0.080 |
Why?
| | Cognition | 1 | 2019 | 1226 | 0.080 |
Why?
| | Injections, Subcutaneous | 1 | 2010 | 164 | 0.080 |
Why?
| | Pyrroles | 1 | 2011 | 207 | 0.080 |
Why?
| | Emotions | 1 | 2016 | 576 | 0.080 |
Why?
| | Blood Glucose | 3 | 2014 | 2286 | 0.080 |
Why?
| | Vitamins | 1 | 2011 | 181 | 0.080 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2017 | 656 | 0.080 |
Why?
| | Triglycerides | 1 | 2012 | 510 | 0.080 |
Why?
| | Postprandial Period | 1 | 2010 | 111 | 0.080 |
Why?
| | Anthropology, Cultural | 1 | 2009 | 21 | 0.080 |
Why?
| | Monitoring, Ambulatory | 1 | 2010 | 90 | 0.080 |
Why?
| | Risk Assessment | 2 | 2009 | 3522 | 0.080 |
Why?
| | Dyslipidemias | 1 | 2011 | 177 | 0.080 |
Why?
| | Mexico | 2 | 2020 | 229 | 0.080 |
Why?
| | Treatment Outcome | 5 | 2014 | 11216 | 0.080 |
Why?
| | Health Care Costs | 1 | 2012 | 417 | 0.070 |
Why?
| | Adiposity | 1 | 2013 | 520 | 0.070 |
Why?
| | Aged | 8 | 2015 | 24836 | 0.070 |
Why?
| | Prevalence | 3 | 2018 | 2795 | 0.070 |
Why?
| | Attitude to Health | 1 | 2011 | 451 | 0.070 |
Why?
| | Safety | 1 | 2010 | 356 | 0.070 |
Why?
| | Sensitivity and Specificity | 2 | 2010 | 1973 | 0.070 |
Why?
| | Pregnancy | 4 | 2023 | 7035 | 0.070 |
Why?
| | Depression | 1 | 2016 | 1490 | 0.060 |
Why?
| | Chi-Square Distribution | 1 | 2008 | 526 | 0.060 |
Why?
| | Retrospective Studies | 4 | 2019 | 16447 | 0.060 |
Why?
| | Brain | 1 | 2019 | 2857 | 0.060 |
Why?
| | Hyperphagia | 2 | 2019 | 39 | 0.060 |
Why?
| | Drug Therapy, Combination | 3 | 2014 | 1043 | 0.060 |
Why?
| | Time Factors | 3 | 2018 | 6951 | 0.060 |
Why?
| | Software | 1 | 2011 | 675 | 0.060 |
Why?
| | Birth Weight | 1 | 2009 | 511 | 0.060 |
Why?
| | Maryland | 1 | 2025 | 60 | 0.060 |
Why?
| | Socioeconomic Factors | 3 | 2017 | 1311 | 0.060 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2006 | 100 | 0.060 |
Why?
| | Albuminuria | 1 | 2006 | 185 | 0.060 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 197 | 0.060 |
Why?
| | Risk Factors | 4 | 2018 | 10490 | 0.060 |
Why?
| | False Negative Reactions | 1 | 2005 | 60 | 0.060 |
Why?
| | Counseling | 1 | 2008 | 395 | 0.060 |
Why?
| | False Positive Reactions | 1 | 2005 | 122 | 0.060 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2010 | 713 | 0.050 |
Why?
| | Cost-Benefit Analysis | 2 | 2005 | 612 | 0.050 |
Why?
| | Thinness | 1 | 2004 | 96 | 0.050 |
Why?
| | Social Class | 1 | 2006 | 269 | 0.050 |
Why?
| | Observation | 2 | 2015 | 56 | 0.050 |
Why?
| | Appetitive Behavior | 1 | 2023 | 8 | 0.050 |
Why?
| | Netherlands | 1 | 2023 | 86 | 0.050 |
Why?
| | Glucose Tolerance Test | 1 | 2005 | 367 | 0.050 |
Why?
| | Sucrose | 1 | 2003 | 111 | 0.050 |
Why?
| | Health Expenditures | 1 | 2005 | 193 | 0.050 |
Why?
| | CpG Islands | 1 | 2023 | 164 | 0.050 |
Why?
| | Satiety Response | 3 | 2008 | 11 | 0.050 |
Why?
| | Psychology, Child | 1 | 2002 | 39 | 0.050 |
Why?
| | Diseases in Twins | 1 | 2002 | 159 | 0.040 |
Why?
| | Dairy Products | 2 | 2014 | 30 | 0.040 |
Why?
| | Treatment Adherence and Compliance | 1 | 2021 | 27 | 0.040 |
Why?
| | Menu Planning | 1 | 2021 | 4 | 0.040 |
Why?
| | Fetal Blood | 1 | 2023 | 335 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2005 | 1505 | 0.040 |
Why?
| | Environment | 1 | 2002 | 342 | 0.040 |
Why?
| | Metformin | 2 | 2014 | 330 | 0.040 |
Why?
| | Food Ingredients | 1 | 2020 | 1 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2003 | 712 | 0.040 |
Why?
| | Agriculture | 1 | 2021 | 99 | 0.040 |
Why?
| | Weight Loss | 4 | 2008 | 794 | 0.040 |
Why?
| | Factor Analysis, Statistical | 2 | 2011 | 296 | 0.040 |
Why?
| | Technology | 1 | 2020 | 95 | 0.040 |
Why?
| | History, 21st Century | 1 | 2020 | 218 | 0.040 |
Why?
| | Computers, Handheld | 1 | 2019 | 26 | 0.040 |
Why?
| | History, 20th Century | 1 | 2020 | 324 | 0.040 |
Why?
| | Family | 2 | 2019 | 677 | 0.040 |
Why?
| | Spinacia oleracea | 1 | 2018 | 9 | 0.040 |
Why?
| | Double-Blind Method | 2 | 2014 | 1992 | 0.030 |
Why?
| | Incidence | 1 | 2005 | 2809 | 0.030 |
Why?
| | United States Department of Agriculture | 1 | 2017 | 4 | 0.030 |
Why?
| | Chicago | 1 | 2017 | 62 | 0.030 |
Why?
| | Non-Randomized Controlled Trials as Topic | 1 | 2017 | 20 | 0.030 |
Why?
| | Serving Size | 1 | 2017 | 1 | 0.030 |
Why?
| | Video Recording | 1 | 2018 | 197 | 0.030 |
Why?
| | Culture | 1 | 2018 | 129 | 0.030 |
Why?
| | Wireless Technology | 1 | 2017 | 17 | 0.030 |
Why?
| | Prospective Studies | 2 | 2021 | 7805 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1408 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2017 | 289 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2002 | 802 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 2018 | 269 | 0.030 |
Why?
| | Research Personnel | 1 | 2017 | 176 | 0.030 |
Why?
| | European Union | 1 | 2014 | 11 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2019 | 1037 | 0.030 |
Why?
| | Research Report | 1 | 2015 | 80 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2018 | 2904 | 0.030 |
Why?
| | Sitagliptin Phosphate | 1 | 2014 | 33 | 0.030 |
Why?
| | Receptors, Glucagon | 1 | 2014 | 26 | 0.030 |
Why?
| | Drug Substitution | 1 | 2014 | 62 | 0.030 |
Why?
| | Alabama | 1 | 2013 | 30 | 0.030 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2014 | 78 | 0.030 |
Why?
| | Societies, Medical | 1 | 2018 | 859 | 0.030 |
Why?
| | Insulin Glargine | 1 | 2014 | 84 | 0.030 |
Why?
| | Cross-Over Studies | 2 | 2008 | 578 | 0.030 |
Why?
| | Urban Population | 1 | 2016 | 482 | 0.030 |
Why?
| | Thiazolidinediones | 1 | 2014 | 134 | 0.030 |
Why?
| | Comorbidity | 1 | 2018 | 1671 | 0.030 |
Why?
| | Play and Playthings | 1 | 2013 | 35 | 0.020 |
Why?
| | Early Medical Intervention | 1 | 2013 | 60 | 0.020 |
Why?
| | Breakfast | 1 | 2013 | 20 | 0.020 |
Why?
| | Deficiency Diseases | 1 | 2012 | 10 | 0.020 |
Why?
| | Endocrine System | 1 | 2012 | 21 | 0.020 |
Why?
| | Food Analysis | 1 | 2012 | 25 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2014 | 771 | 0.020 |
Why?
| | Observer Variation | 1 | 2013 | 356 | 0.020 |
Why?
| | Self Concept | 1 | 2013 | 255 | 0.020 |
Why?
| | 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2011 | 23 | 0.020 |
Why?
| | Administration, Oral | 1 | 2014 | 825 | 0.020 |
Why?
| | Pancreatitis | 1 | 2012 | 136 | 0.020 |
Why?
| | Lipoproteins, LDL | 1 | 2011 | 112 | 0.020 |
Why?
| | Education | 1 | 2011 | 107 | 0.020 |
Why?
| | Risk | 1 | 2013 | 903 | 0.020 |
Why?
| | Diabetes Complications | 1 | 2012 | 222 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2012 | 518 | 0.020 |
Why?
| | Biomedical Research | 1 | 2017 | 684 | 0.020 |
Why?
| | Faculty | 1 | 2011 | 153 | 0.020 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2013 | 291 | 0.020 |
Why?
| | Public Assistance | 1 | 2010 | 20 | 0.020 |
Why?
| | Pediatrics | 1 | 2018 | 1102 | 0.020 |
Why?
| | Cholesterol, LDL | 1 | 2011 | 360 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2012 | 1268 | 0.020 |
Why?
| | Internet | 1 | 2013 | 683 | 0.020 |
Why?
| | Dietary Fiber | 1 | 2008 | 57 | 0.020 |
Why?
| | Kansas | 1 | 2008 | 28 | 0.020 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 449 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2011 | 2047 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3734 | 0.020 |
Why?
| | Health Surveys | 1 | 2008 | 511 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2012 | 1327 | 0.010 |
Why?
| | Universities | 1 | 2008 | 450 | 0.010 |
Why?
| | Dietary Fats, Unsaturated | 1 | 2003 | 24 | 0.010 |
Why?
| | Sample Size | 1 | 2003 | 126 | 0.010 |
Why?
| | Plethysmography, Impedance | 1 | 2002 | 5 | 0.010 |
Why?
| | Videotape Recording | 1 | 2002 | 39 | 0.010 |
Why?
| | Nebraska | 1 | 2002 | 19 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2015 | 7948 | 0.010 |
Why?
| | Abdomen | 1 | 2003 | 138 | 0.010 |
Why?
| | Deuterium Oxide | 1 | 2002 | 16 | 0.010 |
Why?
| | Reference Standards | 1 | 2002 | 180 | 0.010 |
Why?
| | Regression Analysis | 1 | 2004 | 1013 | 0.010 |
Why?
| | Absorptiometry, Photon | 1 | 2002 | 266 | 0.010 |
Why?
| | Inflammation | 1 | 2012 | 2840 | 0.010 |
Why?
| | Fatty Acids | 1 | 2003 | 446 | 0.010 |
Why?
| | Adaptation, Physiological | 1 | 2004 | 561 | 0.010 |
Why?
| | Models, Statistical | 1 | 2003 | 669 | 0.010 |
Why?
| | Exercise Therapy | 1 | 2003 | 453 | 0.010 |
Why?
| | Adipose Tissue | 1 | 2003 | 645 | 0.010 |
Why?
| | Phenotype | 1 | 2002 | 3172 | 0.010 |
Why?
|
|
Johnson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|